BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brockenbrough JS, Morihara JK, Hawes SE, Stern JE, Rasey JS, Wiens LW, Feng Q, Vesselle H. Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation. J Histochem Cytochem 2009;57:1087-97. [PMID: 19654105 DOI: 10.1369/jhc.2009.952804] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Qayyum MI, Ullah S, Rashid U, Sadiq A, Obaidullah, Mahnashi MH, Alshehri OM, Jalal MM, Alzahrani KJ, Halawani IF. Synthesis, Molecular Docking, and Preclinical Evaluation of a New Succinimide Derivative for Cardioprotective, Hepatoprotective and Lipid-Lowering Effects. Molecules 2022;27:6199. [DOI: 10.3390/molecules27196199] [Reference Citation Analysis]
2 Ullah H, Liaqat A, Khan QU, Taha M, Khan F, Rahim F, Uddin I, Rehman ZU. Synthesis, in vitro thymidine phosphorylase activity and molecular docking study of thiadiazole bearing isatin analogs. Chem Pap 2022;76:213-24. [DOI: 10.1007/s11696-021-01842-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Saito Y, Takekuma Y, Yuki S, Komatsu Y, Sugawara M. Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report. Case Rep Oncol 2021;14:207-11. [PMID: 33776705 DOI: 10.1159/000512820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Hooglugt A, van der Stoel MM, Boon RA, Huveneers S. Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature. Front Oncol 2020;10:612802. [PMID: 33614496 DOI: 10.3389/fonc.2020.612802] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
5 Saito Y, Takekuma Y, Komatsu Y, Sugawara M. Hypertriglyceridemia induced by S-1: A novel case report and review of the literature. J Oncol Pharm Pract 2021;27:1020-5. [PMID: 32936722 DOI: 10.1177/1078155220956691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li S, Yang H, Li K, Fan G, Deng L, Xu C. Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma. Cell Biochem Funct 2020;38:743-52. [PMID: 32476180 DOI: 10.1002/cbf.3541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Dorababu A. Evolution of uracil based thymidine phosphorylase inhibitors, SAR and electronic correlation: revisit. Drug Dev Res 2019;80:893-920. [DOI: 10.1002/ddr.21592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Yuan Y, Wang Z, Yang R, Qian T, Zhou Q. Naphthyl quinoxaline thymidine conjugate is a potent anticancer agent post UVA activation and elicits marked inhibition of tumor growth through vaccination. Eur J Med Chem 2019;171:255-64. [PMID: 30925340 DOI: 10.1016/j.ejmech.2019.03.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Takami Y, Yamamoto Y, Ueno M, Chiba Y, Norikane T, Hatakeyama T, Miyake K, Toyohara J, Nishiyama Y. Correlation of 4'-[methyl-11C]-thiothymidine uptake with human equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in patients with newly diagnosed gliomas. Ann Nucl Med 2018;32:634-41. [PMID: 30039191 DOI: 10.1007/s12149-018-1285-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Rapic S, Vangestel C, Verhaeghe J, Thomae D, Pauwels P, Van den Wyngaert T, Staelens S, Stroobants S. Evaluation of [18F]Fluorothymidine as a Biomarker for Early Therapy Response in a Mouse Model of Colorectal Cancer. Mol Imaging Biol 2017;19:109-19. [PMID: 27324368 DOI: 10.1007/s11307-016-0974-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Fiala O, Finek J, Buchler T, Matejka VM, Holubec L, Kulhankova J, Bortlicek Z, Liska V, Topolcan O. The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study. Target Oncol 2015;10:549-55. [PMID: 25875421 DOI: 10.1007/s11523-015-0365-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Elamin YY, Rafee S, Osman N, O Byrne KJ, Gately K. Thymidine Phosphorylase in Cancer; Enemy or Friend? Cancer Microenviron 2016;9:33-43. [PMID: 26298314 DOI: 10.1007/s12307-015-0173-y] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
13 Wei Q, Liu H, Zhou H, Zhang D, Zhang Z, Zhou Q. Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways. BMC Cancer 2015;15:159. [PMID: 25881156 DOI: 10.1186/s12885-015-1149-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
14 Colombara DV, Eidsmoe D, Stern JE, Feng Q, Vesselle H, Hawes SE. No Association between p53 Immunohistochemical Staining and RASSF1 or DAPK1 Hypermethylation in Non-Small Cell Lung Cancer. JCT 2015;06:631-637. [DOI: 10.4236/jct.2015.68069] [Reference Citation Analysis]
15 Bensaber SM, Allafe HA, Ermeli NB, Mohamed SB, Zetrini AA, Alsabri SG, Erhuma M, Hermann A, Jaeda MI, Gbaj AM. Chemical synthesis, molecular modelling, and evaluation of anticancer activity of some pyrazol-3-one Schiff base derivatives. Med Chem Res 2014;23:5120-34. [DOI: 10.1007/s00044-014-1064-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
16 Xiang Y, Zeng H, Liu X, Zhou H, Luo L, Duan C, Luo X, Yan H. Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis. Biomed Rep 2013;1:629-37. [PMID: 24648999 DOI: 10.3892/br.2013.114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Xu Y, Shi QL, Ma H, Zhou H, Lu Z, Yu B, Zhou X, Eriksson S, He E, Skog S. High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma. Tumour Biol 2012;33:475-83. [PMID: 22143937 DOI: 10.1007/s13277-011-0276-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
18 Brockenbrough JS, Souquet T, Morihara JK, Stern JE, Hawes SE, Rasey JS, Leblond A, Wiens LW, Feng Q, Grierson J, Vesselle H. Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors. J Nucl Med 2011;52:1181-8. [PMID: 21764789 DOI: 10.2967/jnumed.111.089482] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
19 Javot L, Spaëth D, Scala-Bertola J, Gambier N, Petitpain N, Gillet P. Severe hypertriglyceridaemia during treatment with capecitabine. Br J Cancer 2011;104:1238-9. [PMID: 21386842 DOI: 10.1038/bjc.2011.52] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
20 Chen YL, Eriksson S, Chang ZF. Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage. J Biol Chem 2010;285:27327-35. [PMID: 20554529 DOI: 10.1074/jbc.M110.137042] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]